Ten Washington state health organizations recently received grants of up to $15,000 from Fred Hutch Cancer Center’s Community ...

At first glance, art and science might seem like opposite worlds — one driven by imagination and emotion, the other by data ...

Dr. Folashade Otegbeye, facility director of the Therapeutic Products Program at Fred Hutch, works to rapidly translate what ...

Faculty profile for Dr. Mohamed Sorror. Dr. Sorror’s research is dedicated to improving the care of patients with aggressive blood cancers who also have health vulnerabilities including being of older ...

In 2024, Obliteride raised more than $9 million for research at Fred Hutch, contributing to more than $58 million raised since 2013. These funds have fueled urgently needed advances in cancer ...

Mignon Loh, MD Division Chief,Pediatric Hematology, Oncology, Blood and Marrow Transplant, and Cellular Therapies Professor of Pediatrics,Hematology-Oncology, UWSOM, Seattle Children's ...

A study from Fred Hutch Cancer Center finds that some cancer patients' antibodies can boost their response to immunotherapy treatment.

The Pacific Northwest Prostate Cancer Specialized Program of Research Excellence (SPORE), one of eight Prostate Cancer SPOREs in the nation, represents a coordinated effort between Fred Hutch and ...

The International Histocompatibility Working Group provides a comprehensive inventory of HLA reference genes to support worldwide research in immunogenetics.

Fred Hutch's mission is the elimination of cancer and related diseases as causes of human suffering and death through prevention and curative treatments accessible to all patients.

In 2023 Fred Hutchinson Cancer Center established the Translational Science and Therapeutics (TST) Division. The division is composed primarily of laboratory-based research groups that work in areas ...

Fred Hutch donors who wish to support a specific type of cancer research or program can give directly to those areas of interest.